ONCT
Oncternal Therapeutics, Inc.
Director Robert James Wills bought $28K of Oncternal Therapeutics, Inc.
Bought$27,655
$8.96Price
3,086Shares
+45%Stake
What ONCT did for a copier
Prices for ONCT after this filing aren't in yet.
Robert James Wills's record
6 other buys on record. A record shows here once 3 of them have 3 months of prices.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Mon, Apr 8. Filed Wed, Apr 10, 4:38 PM ET, after the close. Not investment advice.